Health Secretary Robert F. Kennedy Jr. says his department will devote $100 million toward a pilot program addressing homelessness and substance abuse in eight cities. Monday's announcement builds ...
Midland Reporter-Telegram on MSN
ExxonMobil boosts Delaware Basin output by 60%
ExxonMobil has reached the milestone of producing over 600,000 barrels a day from its Delaware Basin operations.
Philstar.com on MSN
Single contract eyed for LRT-1, MRT-3
For investment viability MANILA, Philippines — The country’s busiest railways – Metro Rail Transit Line 3 (MRT-3) and Light Rail Transit Line 1 (LRT-1) – could end up being managed by a single group ...
Gamuda Bhd's growth runway remains firmly intact, underpinned by a sizeable domestic and overseas project pipeline that could lift its order book to RM50bil by end-2026.
Singapore Business Review on MSN
Construction to outperform as public works anchor $30b–$40b demand: UOB
PUB puts the full DTSS programme at about $10b, whilst the Cross Island Line is seen above S$40b. UOB Kay Hian expects the ...
MoneySmart Blog on MSN
HDB BTO Feb 2026 review: Expected application rates, resale values, amenities, and more
The wait is nearly over—Feb 2026 marks the first Build-to-Order (BTO) exercise of the year, and HDB is kicking things off in a big way. Hot on the heels of 19,600 new flats launched across 28 projects ...
I dive straight into the highlight of the day: the Demon Slayer: Total Concentration Exhibition. This is a must-visit as the global anime phenomenon makes its one and only Southeast Asian stop in 2026 ...
In subjects with elevated cardiovascular disease (CVD) risk, MRT-8102, a NEK7-directed molecular glue degrader in development for the treatment of NLRP3/IL-1/IL-6 driven inflammatory diseases, ...
(MENAFN- GlobeNewsWire - Nasdaq) In subjects with elevated cardiovascular disease (CVD) risk, MRT-8102, a NEK7-directed molecular glue degrader in development for the treatment of NLRP3/IL-1/IL-6 ...
Monte Rosa Therapeutics (GLUE) drew fresh attention after reporting strong interim Phase 1 results for MRT-8102, its NEK7-directed molecular glue degrader. The data showed rapid, sustained reductions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results